You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Non-myeloid malignancy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-Myeloid Malignancy Trial in Beijing (YPEG-rhG-CSF, rhG-CSF/PEG-rhG-CSF)

Completed
  • Non-Myeloid Malignancy
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Feb 7, 2022

Graft Vs Host Disease, Graft-versus-host-disease, Acute Myeloid Leukemia Trial (CliniMACS® device)

Not yet recruiting
  • Graft Vs Host Disease
  • +5 more
  • CliniMACS® device
  • (no location specified)
Jul 20, 2023

Myeloid Leukemia, MDS Trial (IFN-?)

Not yet recruiting
  • Myeloid Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Nov 15, 2023

Hodgkin's Lymphoma, Lymphoid Leukemia, Lymphoma Trial in Richmond (mycophenolate mofetil, Sargramostim, Filgrastim)

Active, not recruiting
  • Hodgkin's Lymphoma
  • +17 more
  • mycophenolate mofetil
  • +2 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
Dec 21, 2021

Venetoclax Tablets Crushed and Dissolved Into a Solution

Not yet recruiting
  • Hematologic Malignancy
  • +18 more
  • 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid) of patients prescribed venetoclax as crushed tablets per standard of care.
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Nov 8, 2023

Colorectal Cancer, Hematologic Malignancy, Rectum Cancer Trial in Cleveland (Vactosertib, Fludarabine Phosphate,

Recruiting
  • Colorectal Cancer
  • +11 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 18, 2023

Outcomes in Chronic Myeloid Leukaemia

Completed
  • Chronic Myeloid Leukaemia
    • York, United Kingdom
      Haematological Malignancy Research Network
    Jun 7, 2023

    Febrile Neutropenia, Non-myeloid Malignancy Trial in Charlotte, Myrtle Beach, Rock Hill (Pegfilgrastim-Cbqv)

    Recruiting
    • Febrile Neutropenia
    • Non-myeloid Malignancy
    • Charlotte, North Carolina
    • +2 more
    Dec 21, 2020

    Haematological Malignancy, Acute Myeloid Leukemia, Non Hodgkin Lymphoma Trial in Worldwide (CCS1477, Pomalidomide,

    Recruiting
    • Haematological Malignancy
    • +4 more
    • Phoenix, Arizona
    • +14 more
    Aug 22, 2022

    AML, AML With Mutated NPM1, Hematologic Malignancy Trial (Ziftomenib, Fludarabine, Idarubicin)

    Not yet recruiting
    • AML
    • +11 more
    • (no location specified)
    Aug 14, 2023

    Myeloid Malignancy, Acute Myeloid Leukemia Trial in Cleveland (Venetoclax, Decitabine)

    Not yet recruiting
    • Myeloid Malignancy
    • Acute Myeloid Leukemia
    • Cleveland, Ohio
      University Hospitals Seidman Cancer, Case Comprehensive Cancer C
    Nov 8, 2023

    Leukemia, Myeloid, Acute, MDS, Hematopoietic Stem Cell Transplantation Trial in Shanghai (Venetoclax plus RIC)

    Not yet recruiting
    • Leukemia, Myeloid, Acute
    • +3 more
    • Venetoclax plus RIC
    • Shanghai, Shanghai, China
      Shanghai General Hospital
    Oct 12, 2022

    Leukemia, Myeloid, Chronic, AML, Leukemia, Lymphocytic, Acute Trial in Minneapolis (biological, drug, radiation)

    Terminated
    Has Results
    • Leukemia, Myeloid, Chronic
    • +8 more
    • Stem Cell Transplant
    • +5 more
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Dec 31, 2020

    Myeloid Malignancy, Acute Myeloid Leukemia, MDS Trial in Rochester (Telehealth Serious Illness Care Program, Education Control)

    Not yet recruiting
    • Myeloid Malignancy
    • +4 more
    • Telehealth Serious Illness Care Program
    • Education Control
    • Rochester, New York
      University of Rochester
    May 24, 2023

    Myeloid Malignancy, MDS, Myelofibrosis Trial in Boston (Navitoclax, Venetoclax, Decitabine)

    Recruiting
    • Myeloid Malignancy
    • +4 more
    • Boston, Massachusetts
    • +2 more
    Jul 21, 2022

    Hypomethylating Agent, Venetoclax, Myeloid Malignancy Trial in Shanghai (Venetoclax, Azacitidine or decitabine)

    Recruiting
    • Hypomethylating Agent
    • +2 more
    • Shanghai, Shanghai, China
      Shanghai Jiao Tong University School of Medicine Affilated Shang
    May 2, 2023

    Acute Myelogenous Leukemia, Multiple Myeloma, MDS Trial in Greece, Spain, United States (This is a non-interventional study)

    Completed
    • Acute Myelogenous Leukemia
    • +6 more
    • This is a non-interventional study
    • Bakersfield, California
    • +19 more
    Apr 4, 2022

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • +6 more
    • Miltenyi CliniMACS Prodigy ® system
    • (no location specified)
    Mar 23, 2023

    Myeloid Malignancies Trial in Chendu (fractionated busulfan-based conditioning regimen)

    Recruiting
    • Myeloid Malignancies
    • fractionated busulfan-based conditioning regimen
    • Chendu, Sichuan, China
      West China Hospital, Sichuan University
    Mar 29, 2023

    Acute Myeloid Leukaemia; MDS;Chronic Myelomonocytic Leukemia Trial in Shenzhen (Azacytidine, HAG Regimen, Azacytidine)

    Recruiting
    • Acute Myeloid Leukaemia; Myelodysplastic Syndromes;Chronic Myelomonocytic Leukemia
    • Shenzhen, Guangdong, China
      Shenzhen Second People's Hospital
    Mar 14, 2022

    Hematologic Malignancy, Myeloid Malignancy Trial in Memphis (Ruxolitinib, Mesna, Anti-thymocyte globulin (ATG))

    Recruiting
    • Hematologic Malignancy
    • Myeloid Malignancy
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Nov 7, 2022

    Acute Myeloid Leukemia Trial in Aurora (Azacitidine, Venetoclax)

    Recruiting
    • Acute Myeloid Leukemia
    • Aurora, Colorado
      Universtiy of Colorado Hospital
    Aug 22, 2022

    Lymphoid Leukemia, Acute, Myeloid Malignancy, Plasma Cell Tumor Trial in Miami (T-cell Receptor a/ß Depleted Donor Lymphocyte

    Recruiting
    • Lymphoid Leukemia, Acute
    • +2 more
    • T-cell Receptor α/β Depleted Donor Lymphocyte Infusions
    • Miami, Florida
      Miami Cancer Institute at Baptist Health, Inc
    May 24, 2022

    Non Hodgkin Lymphoma, Hodgkin Lymphoma, Myeloma Trial in Tampa (CC-486, Duvelisib)

    Recruiting
    • Non Hodgkin Lymphoma
    • +3 more
    • Tampa, Florida
      Moffitt Cancer Center
    Jan 18, 2023

    Tool to Describe HIV-Related Cancer Burden and Patient

    Not yet recruiting
    • HIV-Associated Malignant Neoplasm
    • +7 more
    • Non-Interventional
    • Non-Interventional Follow-up
    • (no location specified)
    Aug 18, 2022